Delivery Order VA25517D0273-36C25519N0519
Award Date
10/1/19
Potential Completion Date
3/16/22
Potential Value
$1.5M
Federal Agency
Veterans Integrated Service Network 15
Awardee
Triad Isotopes, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Orlovista, FL 32811, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of SPECT radiopharmaceuticals to the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 15 (VISN 15) from October 1, 2018 to September 30, 2022. The contract, valued at $1,678,750.24, was awarded on October 1, 2017 to Triad Isotopes, Inc., a for-profit pharmaceutical company that specializes in nuclear medicine. The contract is a firm fixed-price delivery order with no set-aside designation. Triad...
This federal contract award is for the delivery of radiopharmaceuticals to the Department of Veterans Affairs Veterans Health Administration (VA VHA) Veterans Integrated Service Network (VISN) 23. The prime contractor is Triad Isotopes, Inc., a for-profit pharmaceutical company that specializes in nuclear medicine. The contract has a potential value of $306,803.28 and is a Firm Fixed Price Delivery Order with no set-aside designation. Triad Isotopes has provided similar radiopharmaceuticals to...
The U.S. Department of Veterans Affairs Veterans Health Administration awarded a $188,929.02 firm fixed-price delivery order to Triad Isotopes, Inc., a pharmaceutical company specializing in nuclear medicine. The contract is for the delivery of SPECT radiopharmaceuticals to VISN 15 (Veterans Integrated Service Network 15) with no set-aside designation. This award is part of a larger series of contracts between the VA and Triad Isotopes to provide radiopharmaceuticals to VA hospitals...
This federal contract award is for the delivery of radiopharmaceuticals to the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) through the Veterans Integrated Service Network (VISN) 21. The prime contractor is Triad Isotopes, Inc., a pharmaceutical company that specializes in nuclear medicine. The contract has a potential value of $130,474.98 and is a Firm Fixed Price Delivery Order with no set-aside designation. Triad Isotopes has provided similar radiopharmaceuticals...
This is a federal contract award from the Department of Veterans Affairs (VA) Veterans Health Administration to Triad Isotopes, Inc., a pharmaceutical company specializing in nuclear medicine. The contract is for the delivery of radiopharmaceuticals, with a potential value of $152,674.88. The contract has a firm fixed price pricing type and is a delivery order, without a set-aside designation. Triad Isotopes has provided radiopharmaceuticals to the VA's Veterans Integrated Service Network (VISN)...
The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed-price delivery order contract to Triad Isotopes, Inc., a pharmaceutical company that specializes in nuclear medicine, to provide radiopharmaceuticals. The contract has a potential value of $125,065.14 and does not have a set-aside designation. Triad Isotopes has provided similar radiopharmaceuticals to other VA networks, including VISN 15 and VISN 1, to support the VA's delivery of nuclear medicine to...
This federal contract award was made by the Veterans Integrated Service Network 8 (VISN 8), a division of the U.S. Department of Veterans Affairs (VA), to Triad Isotopes, Inc., a pharmaceutical company specializing in nuclear medicine. The $128,160.16 firm fixed-price delivery order is for the provision of radiopharmaceuticals to support the VA's healthcare services for veterans. The contract has no set-aside designation. Triad Isotopes has previously received other VA contract awards to...
This federal contract award is for radiopharmacy services provided by Triad Isotopes, Inc. to the Department of Veterans Affairs Veterans Health Administration. The contract is a definitive contract with a firm fixed price, awarded on October 1, 2017 with a potential value of $405,197.95 and a completion date of September 30, 2019. The contract does not have a set-aside designation. Triad Isotopes, Inc. is a for-profit pharmaceutical company that specializes in nuclear medicine, providing...
This federal contract award was issued by the Department of Veterans Affairs Veterans Health Administration to Triad Isotopes, Inc., a pharmaceutical company that specializes in nuclear medicine and radiopharmaceuticals. The contract is for the delivery of radioactive isotopes, with a firm fixed price and a potential value of $450,630.34. The contract was awarded on October 1, 2017, with a completion date of January 25, 2019. The contract does not have a set-aside designation. Triad Isotopes has...
This is a federal contract award to Triad Isotopes, Inc., a pharmaceutical company that specializes in nuclear medicine, for the provision of various radiopharmaceuticals to the U.S. Department of Veterans Affairs (VA). The contract award, valued at $562,331.07, is a delivery order under a larger contract vehicle. The contract is for the delivery of radiopharmaceuticals to the VA's Veterans Integrated Service Network 1 (VISN 1) and does not have a set-aside designation. Triad Isotopes has...